First pilot study of intrastromal rAAV-PAX6 gene therapy suggests improved corneal thickness and transcription correction in aniridic mouse
Sif G. Kaad, Tess C. Lengyell, Seyedeh Zeinab Mirjalili Mohanna, Diana Djaksigulova, Andrea J. Korecki, Elizabeth M. Simpson · 2026
Read First pilot study of intrastromal rAAV-PAX6 gene therapy suggests improved corneal thickness and transcription correction in aniridic mouse by Sif G. Kaad, Tess C. Lengyell, Seyedeh Zeinab Mirjalili Mohanna, Diana Djaksigulova, Andrea J. Korecki, Elizabeth M. Simpson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13343156.txt.
Description
Sif G. Kaad and co-authors report a 2026 pilot gene therapy test for aniridia, a rare birth condition that steals vision through faults in the PAX6 gene. No cure exists, so the team tried adding a working PAX6 copy into the cornea of aniridic mice using a virus delivered into the corneal stroma.
Mice treated at three months were checked five months after injection. The delivered protein appeared in the stroma, corneal surface thickness improved, and four key signaling genes returned fully to normal reading levels when data were pooled. Sample sizes were small, so the authors treat gains as suggestive. Still, the result opens a path for treating the corneal damage that drives later vision loss.
Catalog record
| CREATOR | Sif G. Kaad, Tess C. Lengyell, Seyedeh Zeinab Mirjalili Mohanna, Diana Djaksigulova, Andrea J. Korecki, Elizabeth M. Simpson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66265 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |